CG Oncology, Inc. (NASDAQ:CGON) IPO
IPO
Priced at US$19.00 a share on Jan 24, 2024.
- Price
- US$19.00 a share
- Shares offered
- 20,000,000 shares of common stock
- Offering size
- US$380 million
- Underwriters' option
- Up to 3,000,000 more shares
- Underwriters
- Morgan Stanley, Goldman Sachs & Co. LLC, Cantor, LifeSci Capital · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Oct 27, 2023 |
| Filed publicly | Jan 2, 2024 |
| Amended twice | Newest Jan 23, 2024 |
| Shares registered with an exchange | Jan 22, 2024 |
| Declared effective by the SEC | Jan 24, 2024 |
| Final prospectus, with the price | Jan 25, 2024 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jan 25, 2024 |
| EFFECT · Notice that a registration is effective | Jan 24, 2024 |
| S-1MEF · Registration of more shares for the same offering | Jan 24, 2024 |
| CERT · Exchange's certificate of listing | Jan 24, 2024 |
| S-1/A · Registration statement, amended | Jan 23, 2024 |
| CORRESP · Letter to the SEC | Jan 22, 2024 |
| CORRESP · Letter to the SEC | Jan 22, 2024 |
| 8-A12B · Registration of shares for listing on an exchange | Jan 22, 2024 |
| S-1/A · Registration statement, amended | Jan 18, 2024 |
| CORRESP · Letter to the SEC | Jan 5, 2024 |
| CORRESP · Letter to the SEC | Jan 2, 2024 |
| S-1 · Registration statement | Jan 2, 2024 |
| UPLOAD · Letter from the SEC | Dec 18, 2023 |
| DRSLTR · Letter to the SEC with a draft | Dec 4, 2023 |
| DRS/A · Draft registration statement, amended | Dec 4, 2023 |
| UPLOAD · Letter from the SEC | Nov 27, 2023 |
| DRS · Draft registration statement | Oct 27, 2023 |
From the cover of the final prospectus (424B4) filed Jan 25, 2024